Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP

NASHVILLE, Tenn., May 20 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the formation of ROSA of Denton, LLP, its fourth joint venture to provide outpatient radiation oncology services. ROSA of Denton is a joint venture between Denton Cancer Center, LP and ASA's subsidiary, Radiation Oncology Services of America, Inc. ROSA of Denton will own and operate a radiation therapy facility in Denton, Texas that was previously owned and operated by Denton Cancer Center.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO )

ROSA of Denton will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT) in the Denton center. The joint venture expects to build on Denton Cancer Center's legacy of providing high-quality cancer care to the residents of the north Dallas area. Tahir Rana, M.D. will serve as medical director for ROSA of Denton.

Dr. Rana, M.D., founder of Denton Cancer Center, said, "I am happy to join with ASA and ROSA. Their management team brings a strong commitment to providing high quality care to patients, and I believe they will be good partners to continue Denton Cancer Center's commitment to caring for cancer patients."

Timothy Martin, President and Chief Executive Officer of ASA, said, "We are excited about the continued growth of our radiation therapy business and our partnership with Dr. Rana and Denton Cancer Center. We look forward to providing excellent care for cancer patients in Denton and the north Dallas area and to working with Dr. Rana to promote the growth and success of ROSA of Denton."

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Renal Services of America, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services. After the acquisition, ASA will own interests in and operate 38 dialysis centers and 11 radiation oncology centers in eight states and the territory of Guam. ASA also manages three other dialysis centers.